Tobacco addiction and the dysregulation of brain stress systems
Open accessThe DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Tobacco is a highly addictive drug and is one of the most widely abused drugs in the world. The first part of this review explores the role of stressors and stress-associated psychiatric disorders in the initiation of smoking, the maintenance of smoking, and relapse after a period of abstinence. The reviewed studies indicate that stressors facilitate the initiation of smoking, decrease the motivation to quit, and increase the risk for relapse. Furthermore, people with depression or an anxiety disorder are more likely to smoke than people without these disorders. The second part of this review describes animal studies that investigated the role of brain stress systems in nicotine addiction. These studies indicate that corticotropin-releasing factor, Neuropeptide Y, the hypocretins, and norepinephrine play a pivotal role in nicotine addiction. In conclusion, the reviewed studies indicate that smoking briefly decreases subjective stress levels but also leads to a further dysregulation of brain stress systems. Drugs that decrease the activity of brain stress systems may diminish nicotine withdrawal and improve smoking cessation rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
Actual Causes of Death in the United States, 2000
Mokdad, A. H. (2004) · JAMA · doi:10.1001/jama.291.10.1238 · Cited by 5,211 · cited 1×
“Worldwide about 5.4 million people die each year from smoking including 400,000 people in the United States and 640,000 in Europe (ASPECT Consortium, 2005; Mokdad et al., 2004; World Health Organization, 2011).”
BackgroundInfluentialAston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878 · cited 2×
“De Lecea and colleagues named these peptides hypocretins because the peptides have a similar amino acid sequence as the gut peptide secretin but their expression was restricted to the hypothalamus (de Lecea et al., 1998).”
BackgroundNarcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 1×
“The hypocretins play a role in the regulation of sleep-wake states and a lack of hypocretin leads to the sleep disorder narcolepsy (Chemelli et al., 1999; Lin et al., 1999; Thannickal et al., 2000).”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Reduced Number of Hypocretin Neurons in Human Narcolepsy
Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., & Siegel, J. M. (2000) · Neuron · doi:10.1016/s0896-6273(00)00058-1 · Cited by 2,089
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
Signs and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
Differential expression of orexin receptors 1 and 2 in the rat brain
Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., & Elmquist, J. K. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1190 · Cited by 1,659
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585 · cited 1×
“The antidepressant drug bupropion has also been shown to improve smoking cessation rates and decrease tobacco withdrawal symptoms such as depression, difficulty concentrating, and irritability (Hurt et al., 1997; Jorenby et al., 1999; Shiffman et al., 2000).”
BackgroundAssessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · cited 1×
“Pioneering studies by Nemeroff, Koob and others showed that CRF plays a critical role in depression and drug addiction (Baldwin et al., 1991; Koob, 1996; Nemeroff et al., 1984).”
BackgroundShape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414 · cited 2×
“A majority of the smokers relapses during the first week of abstinence when the withdrawal symptoms are most severe (Hughes et al., 2004; Jarvis, 2004).”
BackgroundGonzales, D. (2006) · JAMA · doi:10.1001/jama.296.1.47 · Cited by 1,361 · cited 1×
“Although the aforementioned drugs help people quit smoking, relapse rates are still very high (80–85 percent over 1-year period) among people receiving treatment for smoking cessation (Gonzales et al., 2006).”
BackgroundAntidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058 · cited 1×
“Another study reported that the smoking rate among psychiatric outpatients (mean age 31.9 years) with major depression was 49 percent and the smoking rate was 30 percent in a population-based control sample (Hughes et al., 1986).”
BackgroundInfluentialA Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · cited 1×
“The negative affective symptoms associated with smoking cessation may increase the risk for relapse to smoking (Bruijnzeel and Gold, 2005; Koob, 2008).”
BackgroundLewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925 · cited 3×
“Urocortin 1 binds with a slightly higher affinity to the CRF1 receptor than to the CRF2 receptor (Lewis et al., 2001).”
BackgroundNicotine receptor partial agonists for smoking cessation
Cahill, K., Stead, L., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub2 · Cited by 747
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Cryan, J. F., & Mombereau, C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001457 · Cited by 616 · cited 1×
“The antidepressant-like effects of NPY have been investigated in a variety of depression models, including the rat and mouse forced swim test and the rat olfactory bulbectomy model (Cryan and Mombereau, 2004; Kelly et al., 1997).”
BackgroundRole of brain norepinephrine in the behavioral response to stress
Morilak, D. A., Barrera, G., Echevarria, D. J., Garcia, A. S., Hernandez, A., Ma, S., & Petre, C. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.007 · Cited by 570
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565 · cited 2×
“[PubMed: 15870834] Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.”
BackgroundAnhedonia and motivational deficits in rats: Impact of chronic social stress
Rygula, R., Abumaria, N., Flügge, G., Fuchs, E., Rüther, E., & Havemann-Reinecke, U. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.009 · Cited by 554
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., & de Lecea, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507480102 · Cited by 520 · cited 1×
“More recent studies have provided evidence for a role of neuropeptide Y and the hypocretins in the regulation of mood states and drug addiction (Boutrel et al., 2005; Gilpin et al., 2003).”
BackgroundSmoking and mental illness: results from population surveys in Australia and the United States
Lawrence, D., Mitrou, F., & Zubrick, S. R. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-285 · Cited by 517 · cited 6×
“More recent large population-based studies have confirmed that the smoking rate in depressed adults is about twice as high as in control subjects without a mental illness (Lasser et al., 2000; Lawrence et al., 2009).”
BackgroundInfluentialActivation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499 · cited 1×
“Withdrawal from drugs of abuse such as alcohol, nicotine, cocaine, and cannabis leads to an increased release of CRF in the CeA (George et al., 2007; Merlo Pich et al., 1995; Richter and Weiss, 1999; Rodriguez de Fonseca et al., 1997).”
BackgroundPharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492 · cited 1×
“Additional evidence for a role of noradrenergic transmission in tobacco withdrawal is provided by studies with the antidepressant and relative selective norepinephrine reuptake inhibitor nortriptyline (serotonin, 570; NE, 3.4; dopamine, 3500, IC50, reuptake inhibition in vivo)(Hyttel, 1994).”
BackgroundInfluentialEffect of nicotine and nicotinic receptors on anxiety and depression
Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00006 · Cited by 483 · cited 1×
“Studies with animal models indicate that acute nicotine administration can have anxiogenic-like effects (Picciotto et al., 2002).”
BackgroundSymptoms of Tobacco Withdrawal: A Replication and Extension
Hughes, J. R. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250054007 · Cited by 449
Does cigarette smoking cause stress?
Parrott, A. C. (1999) · American Psychologist · doi:10.1037/0003-066x.54.10.817 · Cited by 447 · cited 1×
“However, although smokers indicate that they smoke for stress relief and relaxation, some research suggests that smoking increases subjective stress levels and that smoking does not lead to stress relief but merely reverses the negative mood state caused by nicotine deprivation (Parrott, 1999).”
BackgroundDepressive Symptoms and Cigarette Smoking Among Teens
Goodman, E., & Capitman, J. (2000) · Pediatrics · doi:10.1542/peds.106.4.748 · Cited by 416
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407
Rollema, H., Coe, J. W., Chambers, L. K., Hurst, R. S., Stahl, S. M., & Williams, K. E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.05.003 · Cited by 400
Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking
Hall, S. M., Reus, V. I., Muñoz, R. F., Sees, K. L., Humfleet, G., Hartz, D. T., Frederick, S., & Triffleman, E. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.683 · Cited by 385
Major depression and cigarette smoking: Results of a 21-year longitudinal study
FERGUSSON, D. M., GOODWIN, R. D., & HORWOOD, L. J. (2003) · Psychological Medicine · doi:10.1017/s0033291703008596 · Cited by 374
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366
The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y
Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00066-5 · Cited by 358
Rodent model of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334
Insular hypocretin transmission regulates nicotine reward
Hollander, J. A., Lu, Q., Cameron, M. D., Kamenecka, T. M., & Kenny, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808023105 · Cited by 296
Singh, S., Loke, Y. K., Spangler, J. G., & Furberg, C. D. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110218 · Cited by 286
Fryer, J. D., & Lukas, R. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37928-5 · Cited by 283
Tobacco smoking and depressed mood in late childhood and early adolescence.
Wu, L. T., & Anthony, J. C. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.12.1837 · Cited by 273 · cited 1×
“This finding is in agreement with another study that investigated the effects of smoking on the development of depression in 1731 children and adolescents who were not depressed prior to the onset of smoking (Wu and Anthony, 1999).”
ResultAlpha-2 Adrenergic Receptor Agonists Block Stress-Induced Reinstatement of Cocaine Seeking
Erb, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00158-x · Cited by 270
The effect of bupropion on nicotine craving and withdrawal
Shiffman, S., Johnston, J. A., Khayrallah, M., Elash, C. A., Gwaltney, C. J., Paty, J. A., Gnys, M., Evoniuk, G., & DeVeaugh-Geiss, J. (2000) · Psychopharmacology · doi:10.1007/s002130050022 · Cited by 259
Monoamine oxidase and cigarette smoking
Fowler, J. S., Logan, J., Wang, G.-J., & Volkow, N. D. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(02)00109-2 · Cited by 251 · cited 1×
“There is, however, evidence that other components in tobacco smoke may also have positive reinforcing effects and / or potentiate the effects of nicotine (Fowler et al., 2003; Talhout et al., 2007).”
BackgroundGeorge, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245 · cited 33×
“Immobilization stress increases extracellular levels of norepinephrine in the CeA and these effects are potentiated by the administration of the α2adrenoceptor antagonist yohimbine (Khoshbouei et al., 2002).”
BackgroundMethodInfluentialFeldner, M. T., Babson, K. A., & Zvolensky, M. J. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.08.004 · Cited by 240
Characterization of spontaneous and precipitated nicotine withdrawal in the mouse
Damaj, M. I., Kao, W., & Martin, B. R. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054908 · Cited by 222 · cited 2×
“Nicotine withdrawing mice have also been shown to display increased anxiety-like behavior in the elevated plus maze test and the light-dark box test (Costall et al., 1989; Damaj et al., 2003; Jonkman et al., 2005).”
BackgroundWatkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214 · cited 2×
“The discontinuation of chronic nicotine administration and the administration of nAChR antagonists to nicotine dependent rats has been shown to lead to elevations in brain reward thresholds in rats (Epping-Jordan et al., 1998; Watkins et al., 2000).”
Backgroundkappa-Opioid receptor signaling and brain reward function
Bruijnzeel, A. W. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.09.008 · Cited by 214 · cited 1×
“For an overview of the role of acetylcholine, dynorphin, and other neurotransmitters in nicotine addiction, the readers are referred to previous reviews (Balfour, 2009; Bruijnzeel, 2009; Castane et al., 2005; Dani and Balfour, 2011; Maldonado and Berrendero, 2010; Markou, 2007).”
BackgroundSelf-citationDo glucocorticoid concentrations rise with age in the rat?
Sapolsky, R. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90025-s · Cited by 209 · cited 1×
“Corticosterone prepares the body for acute stressors by mobilizing energy stores and suppressing physiological processes that are temporarily unessential for survival (McEwen, 2000; Sapolsky, 1992).”
BackgroundStress reinstates nicotine seeking but not sucrose solution seeking in rats
Buczek, Y., Lê, A. D., Wang, A., Stewart, J., & Shaham, Y. (1999) · Psychopharmacology · doi:10.1007/s002130050992 · Cited by 206 · cited 1×
“Similar to other drugs of abuse, nicotine seeking behavior can be reinstated by exposing rats to footshocks, nicotine, or cues associated with the self-administration of nicotine (Buczek et al., 1999; O'Connor et al., 2010; Paterson et al., 2005).”
BackgroundKoenen, K. C., Hitsman, B., Lyons, M. J., Niaura, R., McCaffery, J., Goldberg, J., Eisen, S. A., True, W., & Tsuang, M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1258 · Cited by 197
Self-perceived smoking motives and their correlates in a general population sample
Fidler, J. A., & West, R. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp120 · Cited by 194
al’Absi, M., Hatsukami, D., Davis, G. L., & Wittmers, L. E. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.10.014 · Cited by 193 · cited 1×
“It has been shown that smokers who relapse during the first week have a greater decrease in cortisol levels on the first day of abstinence compared to smokers who are able to maintain abstinence for at least one week (al'Absi et al., 2004).”
Backgroundal’Absi, M., Hatsukami, D., & Davis, G. L. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2225-3 · Cited by 192 · cited 1×
“In one study, the relationship between stressinduced activation of the HPA axis and relapse over a 4-week period was investigated (al'Absi et al., 2005).”
BackgroundThe actions of nicotine and cocaine in a mouse model of anxiety
Costall, B., Elizabeth Kelly, M., Naylor, R. J., & Onaivi, E. S. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90450-4 · Cited by 186 · cited 1×
“Nicotine withdrawing mice have also been shown to display increased anxiety-like behavior in the elevated plus maze test and the light-dark box test (Costall et al., 1989; Damaj et al., 2003; Jonkman et al., 2005).”
BackgroundHeilig, M., Zachrisson, O., Thorsell, A., Ehnvall, A., Mottagui-Tabar, S., Sjögren, M., Åsberg, M., Ekman, R., Wahlestedt, C., & Ågren, H. (2004) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00101-8 · Cited by 177 · cited 2×
“A similar pattern of results was observed by Heilig and colleagues (Heilig et al., 2004).”
BackgroundResultAntidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test
Farzin, D., & Mansouri, N. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.08.005 · Cited by 171 · cited 1×
“Norharman and harman have antidepressant-like effects in rodents (Aricioglu and Altunbas, 2003; Farzin and Mansouri, 2006) and clinical studies indicate that drugs that inhibit MAO-A, but not MAO-B, have antidepressant effects in humans (Blier and de Montigny C., 1994).”
BackgroundZvolensky, M. J., Stewart, S. H., Vujanovic, A. A., Gavric, D., & Steeves, D. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntn037 · Cited by 158 · cited 1×
“It has also been reported that increased anxiety sensitivity (i.e., fear of being anxious) increases the risk for a lapse to smoking during the first 2 weeks after quitting but does not affect full blown relapse to smoking during the same time period (Zvolensky et al., 2009).”
BackgroundPauly, J. R., Marks, M. J., Gross, S. D., & Collins, A. C. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20464-5 · Cited by 152 · cited 1×
“…in heart rate and body temperature) and behavioral (e.g., decrease in locomotor activity and rearing) effects of nicotine and an upregulation of α4β2 and α7-containing nAChRs in rats and mice (Pauly et al., 1991; Pauly et al., 1992; Small et al., 2010; Stolerman et al., 1973; Yates et al., 1995).”
BackgroundPiper, M. E., Smith, S. S., Schlam, T. R., Fleming, M. F., Bittrich, A. A., Brown, J. L., Leitzke, C. J., Zehner, M. E., Fiore, M. C., & Baker, T. B. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0018065 · Cited by 150
Withdrawal from Chronic Nicotine Administration Impairs Contextual Fear Conditioning in C57BL/6 Mice
Davis, J. A., James, J. R., Siegel, S. J., & Gould, T. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2853-05.2005 · Cited by 146
Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain
Jorenby, D. E., Hatsukami, D. K., Smith, S. S., Fiore, M. C., Allen, S., Jensen, J., & Baker, T. B. (1996) · Psychopharmacology · doi:10.1007/s002130050118 · Cited by 141 · cited 1×
“…in positive affect, an increase in negative affect, craving for tobacco, irritability, anxiety, difficulty concentrating, hyperphagia, restlessness, and a disruption of sleep (Caan et al., 1996; Cook et al., 2004; Hughes and Hatsukami, 1986; Jorenby et al., 1996; Zhdanova and Piotrovskaya, 2000).”
BackgroundPauly, J. R., Marks, M. J., Robinson, S. F., van de Kamp, J. L., & Collins, A. C. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20143-4 · Cited by 126
Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training
Gould, T. J., & Stephen Higgins, J. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00057-1 · Cited by 123
Ouagazzal, A.-M., Kenny, P. J., & File, S. E. (1999) · Psychopharmacology · doi:10.1007/s002130050976 · Cited by 121
Motives for smoking and their correlates in clients attending Stop Smoking treatment services
McEwen, A., West, R., & McRobbie, H. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802027248 · Cited by 120
van der Velden, P. G., Kleber, R. J., & Koenen, K. C. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.11.001 · Cited by 108 · cited 1×
“…smoking increases the risk for developing PTSD. Van der Velden and colleagues investigated the association between smoking and the development of PTSD in rescue workers who were involved in the Enschede fireworks explosion that killed 23 people and destroyed 500 homes (Van der Velden et al., 2008).”
BackgroundBell, S., Taylor, R., Singleton, E., Henningfield, J., & Heishman, S. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011141 · Cited by 107 · cited 1×
“Smoking during the acute withdrawal phase reduces craving for cigarettes and returns cognitive abilities to pre-smoking cessation levels (Bell et al., 1999).”
BackgroundZvolensky, M., Gibson, L., Vujanovic, A., Gregor, K., Bernstein, A., Kahler, C., Legues, C. W., Brown, R., & Feldner, M. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802238951 · Cited by 104 · cited 1×
“However, both the PTSD patients and the patients with other anxiety disorders were more likely to relapse than the control subjects and there was no difference in relapse rates between the PTSD patients and the patients with other anxiety disorders (Zvolensky et al., 2008).”
BackgroundGilpin, N. W., Misra, K., & Koob, G. F. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.04.006 · Cited by 97 · cited 1×
“Furthermore, the administration of NPY in the CeA decreases alcohol intake in alcohol dependent animals but not in nondependent control animals (Gilpin et al., 2008).”
BackgroundNijsen, M. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00167-6 · Cited by 92 · cited 1×
“Extrahypothalamic CRF orchestrates behavioral and autonomic responses to stressors (Koob and Heinrichs, 1999; Nijsen et al., 2001).”
BackgroundThorsell, A., Repunte-Canonigo, V., O'Dell, L. E., Chen, S. A., King, A. R., Lekic, D., Koob, G. F., & Paolo Sanna, P. (2007) · Brain · doi:10.1093/brain/awm033 · Cited by 91 · cited 1×
“Viral vector-induced overexpression of NPY in the CeA decreases alcohol intake in alcohol dependent animals (Thorsell et al., 2007).”
BackgroundIrvine, E. E., Cheeta, S., & File, S. E. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199911000-00016 · Cited by 89 · cited 2×
“However, several studies suggest that animals develop tolerance to the anxiogenic-like effects of nicotine in the elevated plus maze test and the social interaction test after about 7 days of treatment (Irvine et al., 1999; Irvine et al., 2001).”
BackgroundMethodTolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal
Irvine, E. E., Cheeta, S., & File, S. E. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00449-4 · Cited by 88
Gilpin, N. W., Stewart, R. B., Murphy, J. M., Li, T., & Badia‐Elder, N. E. (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000065723.93234.1d · Cited by 76 · cited 1×
“More recent studies have provided evidence for a role of neuropeptide Y and the hypocretins in the regulation of mood states and drug addiction (Boutrel et al., 2005; Gilpin et al., 2003).”
BackgroundWatanabe, T., Nakagawa, T., Yamamoto, R., Maeda, A., Minami, M., & Satoh, M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1504-0 · Cited by 71 · cited 1×
“Morphine withdrawal mediates an increased release of norepinephrine in the prefrontal cortex, CeA, and BNST (Devoto et al., 2002; Fuentealba et al., 2000; Watanabe et al., 2003).”
BackgroundYates, S. L., Bencheri, M., Fluhler, E. N., & Lippiello, P. M. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02100-0 · Cited by 65 · cited 1×
“…in heart rate and body temperature) and behavioral (e.g., decrease in locomotor activity and rearing) effects of nicotine and an upregulation of α4β2 and α7-containing nAChRs in rats and mice (Pauly et al., 1991; Pauly et al., 1992; Small et al., 2010; Stolerman et al., 1973; Yates et al., 1995).”
BackgroundNicotine and Hippocampus-Dependent Learning: Implications for Addiction
Gould, T. J. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:2:93 · Cited by 61
Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors
Woldbye, D. P. D., Klemp, K., & Madsen, T. M. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37249-0 · Cited by 54 · cited 2×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript addition, NPY and other NPY receptor agonists such as [Leu31, Pro34]-NPY, NPY 3–36, and peptide YY decrease somatic opioid withdrawal signs in rats (Woldbye et al., 1998).”
BackgroundResultNicotine receptor partial agonists for smoking cessation
Cahill, K., Stead, L. F., & Lancaster, T. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub4 · Cited by 46
Nicotine and extinction of fear conditioning
Elias, G. A., Gulick, D., Wilkinson, D. S., & Gould, T. J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.022 · Cited by 36
Mild anxiogenic effects of nicotine withdrawal in mice
Jonkman, S., Henry, B., Semenova, S., & Markou, A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.032 · Cited by 35
Depression and the Dynamics of Smoking: A National Perspective
Anda, R. F. (1990) · JAMA · doi:10.1001/jama.1990.03450120053028 · Cited by 28
Prinstein, M. J., & La Greca, A. M. (2009) · Health Psychology · doi:10.1037/a0013949 · Cited by 26
Cited by
Bossert, J. M., Marchant, N. J., Calu, D. J., & Shaham, Y. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3120-y · Cited by 453
Inoculation stress hypothesis of environmental enrichment.
Crofton, E. J., Zhang, Y., & Green, T. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.017 · Cited by 206
“For humans, stress increases the likelihood that someone will start smoking along with increasing the risk of relapse to cigarette smoking (Bruijnzeel, 2012).”
BackgroundStress is a principal factor that promotes tobacco use in females
Torres, O. V., & O'Dell, L. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.04.005 · Cited by 164
Lifestyle management of unipolar depression
Berk, M., Sarris, J., Coulson, C. E., & Jacka, F. N. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12124 · Cited by 111
“Tobacco dysregulates the stress response systems, which are part of the pathophysiology of depression (161).”
BackgroundStress modulates illness-course of substance use disorders: a translational review
Lijffijt, M., Hu, K., & Swann, A. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00083 · Cited by 103
“(101)], suggesting increased initiation or relapse.”
Metadata
- Authors
- Bruijnzeel, A. W.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 36
- Issue
- 5
- Pages
- 1418-1441
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2063478738
- Cited by
- 173
- References
- 96
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.